Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (As Restated) (Details)

v3.20.4
Summary of Significant Accounting Policies (As Restated) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Summary of Significant Accounting Policies (Textual)          
Common stock subject to possible redemption, shares 0   0   33,618
Income tax benefit (expense) $ (3,827) $ 51,345 $ 217,583  
Successors [Member]          
Summary of Significant Accounting Policies (Textual)          
Common stock subject to possible redemption, shares 0   0   33,618
Description of net income (loss) per common share     The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and Private Placement to purchase 6,001,250 shares of common stock, (2) warrants earned (currently unissued) to purchase 28,935 shared of common stock as of September 30, 2020; and (3) rights sold in the Initial Public Offering and Private Placement that convert into 1,200,250 shares of common stock, in the calculation of diluted income per share, since the exercise of the warrants and the conversion of the rights into shares of common stock is contingent upon the occurrence of future events and the inclusion of such warrants and rights would be anti-dilutive under the treasury stock method.    
Federal depository insurance coverage amount $ 250,000   $ 250,000    
Cash and marketable securities held in trust account 10,303,227   10,303,227   $ 11,877,654
Deferred tax assets 1,334,000   1,334,000   407,000
Deferred tax assets, Valuation allowance $ 1,334,000   $ 1,334,000   $ 407,000
Income tax expense       $ 218,000  
Effective tax rate 0.20%   0.00% 52.20%  
Income tax benefit (expense) $ 3,827   $ 0    
Business Combination Agreement [Member]          
Summary of Significant Accounting Policies (Textual)          
Income tax expense   $ 51,000      
Effective tax rate   173.70%